Top 5 reasons to locate your next clinical trial in Hungary
Hungary is placed 10th worldwide in terms of the number of trials conducted in the country and 4th in Europe (based on population-proportional patient numbers). Each year approximately 20,000 patients participate in clinical trials. Cromos Pharma established its office in Budapest, Hungary in 2016. 5 Top Reasons to Choose Hungary An EU member state, Hungary
European Medicines Agency: Approvals January 2021
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended 13 new medications for approval and three therapeutic indication extensions in its January 2021 meeting. Source: EMA Highlights A conditional marketing authorisation for COVID-19 Vaccine AstraZeneca (COVID-19 Vaccine (ChAdOx1-S [recombinant])) Seffalair Spiromax (salmeterol / fluticasone) and its duplicate BroPair Spiromax (salmeterol / fluticasone) received a positive opinion for the
Upcoming EU drug/device legislation: What you need to know
Zsolt Kocsis, Cromos Pharma’s Head of EU Operations explores some of the upcoming changes to EU legislation in relation to drug development and medical devices. This video offers a practical breakdown of all you need to know about the upcoming changes if you are involved in pharma, clinical research, medtech or biotech. This presentation
